FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 260 filers reported holding FATE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $36,246 | -78.4% | 6,359 | +181.0% | 0.00% | -66.7% |
Q1 2021 | $168,000 | -88.5% | 2,263 | -85.5% | 0.00% | -90.6% |
Q4 2020 | $1,459,000 | +262.0% | 15,586 | +52.5% | 0.03% | +146.2% |
Q3 2020 | $403,000 | -25.5% | 10,219 | -38.3% | 0.01% | -31.6% |
Q2 2020 | $541,000 | – | 16,575 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JOHNSON & JOHNSON | 3,379,064 | $7,163,616 | 2.64% |
Redmile Group, LLC | 13,124,427 | $27,823,785 | 1.32% |
Monaco Asset Management SAM | 1,847,944 | $3,917,641 | 1.16% |
Casdin Capital, LLC | 2,050,000 | $4,346,000 | 0.48% |
TANG CAPITAL MANAGEMENT LLC | 700,000 | $1,484,000 | 0.21% |
GCM Grosvenor Holdings, LLC | 495,916 | $1,051,342 | 0.21% |
Nebula Research & Development LLC | 163,617 | $346,868 | 0.18% |
Bellevue Group AG | 4,851,579 | $10,285,347 | 0.17% |
Bruce & Co., Inc. | 200,000 | $424,000 | 0.14% |
XTX Topco Ltd | 192,920 | $408,990 | 0.07% |